Synopsis of recent research by authors named "Rubeena Hakak"
- Rubeena Hakak's research primarily focuses on dermatological infections and their treatment outcomes, specifically exploring the efficacy and relapse rates associated with oral terbinafine therapy in patients diagnosed with dermatophytosis.
- In her 2016 study, she identified a notable trend of incomplete cures and recurrent fungal infections after a standard 2-week course of oral terbinafine, emphasizing the need for improved management strategies for tinea infections.
- Earlier in her career, Hakak investigated immunological responses in co-infection scenarios, revealing that the presence of Heligmosomoides polygyrus hampers the development of effective CD8+ T-cell immunity against Toxoplasma gondii, highlighting important interactions in immune response dynamics.
